Sleep is prescribed the same way exercise is prescribed in the Relapsd protocols: not as lifestyle advice, but as a clinically meaningful variable that directly affects recovery speed.
What Happens During Sleep
Slow-wave sleep (N3):
- Receptor resynthesis: Receptors (nAChRs, CB1, GABA-A) are membrane proteins that require synthesis and insertion during the recovery phase. Protein synthesis occurs primarily during slow-wave sleep.
- Synaptic homeostasis: The synaptic homeostasis hypothesis suggests that synaptic potentiation that accumulates during waking is normalized during slow-wave sleep-this is the primary mechanism of memory consolidation and synaptic optimization.
- Glymphatic clearance: The glymphatic system (glial-lymphatic system) clears metabolic waste from the brain during sleep, including potentially neurotoxic proteins that accumulate during stress and substance use.
REM sleep:
- Emotional memory processing
- Cortical-subcortical connectivity optimization
- Hippocampal replay and consolidation
The growth hormone connection: 70-80% of daily growth hormone (GH) is secreted during the first few hours of slow-wave sleep. GH promotes tissue repair, including neural tissue repair. Disrupted sleep reduces GH release.
How Each Substance Disrupts Sleep
Nicotine: Activates cholinergic circuits; reduces deep sleep and fragments sleep architecture. Cessation produces REM rebound in some users.
Cannabis: Suppresses REM during use. Cessation produces intense REM rebound for 2-4 weeks (the primary sleep symptom of cannabis withdrawal).
Alcohol: Sedating initially; produces fragmented sleep in the second half of the night as blood alcohol drops. Cessation produces elevated CNS activity that impairs sleep onset and maintenance.
The Protocol Response
Each protocol includes substance-specific sleep support:
NIC: Magnesium Glycinate (GABA support, sleep quality) + L-Theanine (alpha wave induction, sleep onset)
GREEN: Magnesium L-Threonate (blood-brain barrier penetration, superior for CNS effects) + Apigenin (GABA-A partial agonist, anxiolytic/sleep) + Low-dose Melatonin 0.3mg (circadian support without suppressing endogenous production)
DRY: Magnesium Glycinate (GABA-A support) + B-vitamin complex (multiple sleep-relevant pathways)
The Compounding Problem
Poor sleep → slower receptor recovery → more severe daytime withdrawal symptoms → more craving events → more relapse risk → if relapsed, sleep disrupted again.
Good sleep → accelerated receptor recovery → reduced withdrawal severity → reduced craving frequency → improved cessation success.
Sleep is not a luxury during recovery. It is the environment in which recovery happens.
Target: 7-9 hours per night, consistent sleep and wake times, dark and cool environment. These are clinical parameters, not wellness suggestions.